US20030119203A1 - Lateral flow assay devices and methods for conducting assays - Google Patents

Lateral flow assay devices and methods for conducting assays Download PDF

Info

Publication number
US20030119203A1
US20030119203A1 US10035014 US3501401A US20030119203A1 US 20030119203 A1 US20030119203 A1 US 20030119203A1 US 10035014 US10035014 US 10035014 US 3501401 A US3501401 A US 3501401A US 20030119203 A1 US20030119203 A1 US 20030119203A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
membrane
analyte
calibration
probe
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10035014
Inventor
Ning Wei
Xuedong Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimberly-Clark Worldwide Inc
Original Assignee
Kimberly-Clark Worldwide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody

Abstract

Disclosed is a method and apparatus for employing, in a lateral flow assay, multiple control lines to assist in improving the sensitivity of such an assay. Analytes of interest may be quantified in a lateral flow assay by conducting internally derived calibrations by quantifying the analyte and calibrating the assay device, at essentially the same time, on the same device. That is, calibration and sample testing may occur simultaneously, improving sensitivity, and reducing errors that otherwise may be introduced by comparing data produced in one assay with data or reference data produced in a different assay. A multi-point calibration technique may be employed. Visual spectrophotographic reading devices may be employed to compare intensity of signals generated by probes attached to the analyte with probes associated with control lines upon a calibration zone.

Description

    BACKGROUND OF THE INVENTION
  • [0001]
    Membrane-based test devices, particularly devices used in diagnostic medicine, employ a variety of internal and external calibrators to provide a qualitative or a quantitative result for an analyte of interest in a test solution. One type of membrane-based test device is a lateral flow assay.
  • [0002]
    In general, lateral flow assays are membrane-based test devices in which a sample that is suspected of containing the analyte of interest is placed at or near one end of a membrane strip. The sample is carried to the opposite end of the membrane strip by a liquid phase that traverses the membrane strip by capillary action. While traversing the membrane strip, the analyte in the test sample, if any, encounters one or more “capture” reagents with which it may react to produce a detectable signal.
  • [0003]
    The early types of immunochromatography devices, such as those taught in U.S. Pat. No. 4,366,241 (Tom et al.), lacked an internal reference. Later devices, such as taught in U.S. Pat. No. 4,374,925 (Litman) do indeed employ an internal reference. In some instances, the internal references used have required fairly laborious cross-referencing to achieve results.
  • [0004]
    One known membrane-based test device is the dipstick. The dipstick is a stick having a small reagent impregnated membrane (stripped with capture reagents on different zones and wicking pads on one end and the other) end for dipping into a test solution either containing or suspected of containing the analyte of interest. The dipstick membrane (hereinafter “dipstick”) develops a color that is proportional to the concentration of the analyte of interest in the test sample. Typically, the user determines the concentration of the analyte by comparing the color on the membrane to the color on an external calibration, such as a series of colored plates that are printed on a label. This is a subjective determination.
  • [0005]
    External calibration of a dipstick, via colored plates, provides several problems. First, it is difficult to accurately match the color of the plates with the color on the dipstick. Secondly, the color on the plates would not fade in proportion to the adverse conditions affecting the color on the dipstick. Further, the color on the plates would at best only be accurate for a particular set of reaction conditions.
  • [0006]
    Many of such devices and methods rely upon calibration to provide valid and meaningful results for semi-quantitative and quantitative detections. Calibration methods are often critical to provide accurate, reliable and reproducible results, especially when the environments and conditions under which the measurements are commenced are not carefully controlled. Two calibration methods, external and internal calibrations, are commonly employed. In the external calibration method, a standard curve is usually obtained from standard samples containing a series of a known amount of analyte, and the results obtained from the samples are then compared with the standard curve to extract the information regarding the presence and/or amount of the analyte in the sample. External calibration methods are often subject to interference from environmental and batch-to-batch variations, and sometimes are not reliable. When an instrument or measuring device is used, it is also subject to interference from the instability of the instrument or device.
  • [0007]
    In general, lateral flow assay methods are limited in their sensitivity by not using an internal calibration mechanism that takes into account widely varying differences in temperature, flow conditions, capillary action, pressure, and other factors that affect movement or deposition of analyte on a membrane or support. Any system that compares the migration characteristics of analyte on a given test strip with references taken on another separate strip at another time and place will not achieve maximum sensitivity and accuracy.
  • [0008]
    What is needed in the industry is a lateral flow assay system and method having improved sensitivity in relation to existing methods and devices. The invention of this application is directed to such an application.
  • SUMMARY OF THE INVENTION
  • [0009]
    A lateral flow assay system, apparatus, and method are provided in the invention. The assay provides a method to detect the quantity of analyte residing in a test solution. The assay further comprises a probe. The probe may be of various types. Probes are configured for generating a detectable signal. Probes may be covalently reacted with antibody to form probe-conjugates and this conjugate then may travel to react with analyte to form a probe-conjugate analyte complex (or “sandwich”). Once this species is immobilized upon a detection zone it is referred to as a “sandwich complex”. All these described species may be able to migrate on a membrane and may be used for analyte detection.
  • [0010]
    A membrane may be configured to provide a sample pad, conjugate pad, detection zone, calibration zone and wicking pad. On the conjugate pad the probes and probe-conjugates may be dried down upon the membrane and made available for analyte as the analyte moves along the membrane from one end of the membrane to the other end. When analyte molecules join probe conjugates, they form probe conjugate analyte complexes, which are capable of becoming mobilized, and moving to a detection zone.
  • [0011]
    Upon the detection zone, a first capture reagent may be immobilized. The first capture reagent may be composed of any ligand specific binder, thus, one example of such a capture reagent is an antibody. This first capture reagent may immobilize such probe-conjugate analyte complexes to form a “sandwich complex”, or “sandwich” upon the detection zone.
  • [0012]
    A calibration zone also may be provided. The calibration zone comprises at least two control lines, however, in some applications of the invention, three, four, or more control lines may be provided. The control lines may have applied thereon a predetermined amount of a second capture reagent. The second capture reagent may be configured to immobilize probe-conjugates or probes that migrate to the control lines without analyte, thereby positioning them for generating a calibration or control signal.
  • [0013]
    In general, each control line may have a predetermined amount of the second capture reagent. Thus, commonly, the first control line nearest the detection zone may have the least amount of second capture reagent, while the last control line furthest from the detection zone may have the greatest amount of second capture reagent. In some applications, the control lines may vary by predetermined amount from each other, so as supply a suitable calibration curve, as shown in herein and described with reference to FIG. 2.
  • [0014]
    Some applications of the invention utilize visual comparisons. In other applications, reading devices such as reflectometer or spectrophotometer may be employed to compare the intensity of signals generated with reference standards that are generated in the assay. Spectrophotometric methods may be employed to compare the intensity of signals generated with reference standards that are generated in the course of the assay.
  • [0015]
    In some applications, a calibration data curve may be generated using signal intensity data generated from the control lines. The curve may provide a “look-up table” that may be automatically applied in an algorithm of an analytical instrument.
  • [0016]
    The probe in some cases may comprise a microparticle that is capable of generating a visual signal, such as a latex bead, for example, that includes red or blue or another colored dye. In other applications, the probe may generate fluorescent signals that are detectable and are proportional to the amount of such species in a given zone.
  • [0017]
    The invention may be directed to a method for detecting the quantity of an analyte in a test solution. The method may include applying a plurality of probes that are configured for migrating to preselected locations and, when they become sandwich complexes, generating a detectable signal.
  • [0018]
    Internal calibration methods are useful because such methods may provide more accurate, more reliable and more reproducible results than external calibration methods. Using internal calibration methods, signals related to the analyte in the sample are usually measured at the same time and/or upon the same membrane device that generates the calibration signals. The simultaneous measurements can eliminate some potential interference to provide more consistent and sensitive detections.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0019]
    A full and enabling disclosure of this invention, including the best mode shown to one of ordinary skill in the art, is set forth in this specification. The following Figures illustrate the invention:
  • [0020]
    [0020]FIG. 1 is a top view of one embodiment of the invention, showing a lateral flow assay having three control lines in a calibration zone;
  • [0021]
    [0021]FIG. 1A shows a perspective schematic view of the movement of fluids and the formation of complexes upon the surface of the membrane strip of a lateral flow assay, showing the membrane strip after a test sample containing analyte has been applied to the sample pad,
  • [0022]
    [0022]FIG. 1B shows the same schematic view of the membrane test strip shown in FIG. 1A, but at a later time after migration of fluids have occurred and complexes have formed; and
  • [0023]
    [0023]FIG. 2 shows a calibration curve that may be used in some applications of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0024]
    Reference now will be made to the embodiments of the invention, one or more examples of which are set forth below. Each example is provided by way of explanation of the invention, not as a limitation of the invention. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in this invention without departing from the scope or spirit of the invention.
  • [0025]
    The invention makes it possible to use multiple control lines to quantify analytes of interest in a lateral flow assay format. In particular, the method and apparatus of the invention relate to conducting internal calibrations by: (1) quantifying the analyte and (2) calibrating the assay device, at about the same time, on the same membrane device. That is, calibration and sample testing may occur on the same device, by affording a built-in calibration data curve generated using the testing device. A multi-point calibration technique may be employed in a lateral flow assay format.
  • [0026]
    The method may be used for quantitative and semi-quantitative detection. The probes used may reveal color intensity, fluorescence intensity, as examples. The probes for control lines may be microparticles such as latex beads, for example, labeled with essentially any signal generating species. Alternately, the probes may comprise labeled latex beads further conjugated with antibodies, as further described herein. The antibodies may be dried upon the conjugate zone of the membrane.
  • [0027]
    Various amounts of predetermined capture reagents may be provided on solid substrates, such as porous membranes, to form multiple control lines for calibration purposes. In yet another embodiment, the capture reagents may be antibodies. In yet another embodiment, the capture reagents may be any molecules which are capable of forming strong interactions with probes and/or probe conjugates.
  • [0028]
    The membrane-based device of the invention comprises several components, including a membrane, a sample pad, a conjugate pad and a wicking pad, or a combination of these items. The membrane typically includes at least two zones, that is, a detection zone and a control zone. A sample pad contacts one end of the conjugate pad.
  • [0029]
    One design of the assay device includes a liquid sample flow direction through a sample pad, conjugate pad, detection zone of the membrane, control zone of the membrane, and wicking pad. In general, the wicking pad assists in promoting capillary action and fluid flow one-way through the membrane of the device, and the wicking pad “pulls” the liquid containing the analyte along the membrane from one end of the membrane to another end of the membrane.
  • [0030]
    Turning now to FIG. 1, a lateral flow assay 20 is provided in top view. The lateral flow assay 20 comprises a membrane 23 as a solid support, and includes a sample pad 21. The sample pad 21 is configured to receive a liquid sample containing analyte 40 (seen in FIG. 1A). A conjugate pad 22 is provided further “downstream” of capillary movement direction 29, as shown by the arrow on the left side of the FIG. 1.
  • [0031]
    Conjugate pad 22 typically contains probes 41 and probe conjugates 42 (see FIG. 1A) in a form that makes the probe conjugates available for bonding with the analyte 40 as the analyte 40 passes from the sample pad 21. A typical method employs microparticles as probes 41, and their conjugate deposited on the conjugate pad 22. Such particles may be comprised of latex, or other suitable material, as further described herein. Latex microparticles, when used as probes, may be colored with dyes that are visible to the eye, or to detection apparatus. Sometimes a probe 41 emits light (as in the case of fluorescence methods), or the probe 41 may be detected by other techniques once it has migrated and complexed, as further described herein.
  • [0032]
    A detection zone 31 is shown in FIG. 1. The detection zone 31 may comprise an immobilized capture reagent along detection line 24, as further described in connection with FIG. 1A. A calibration zone 32 is shown with three control lines 25-27. A wicking pad 28 also is shown.
  • [0033]
    Referring to FIG. 1A, a membrane 23 is provided in which molecules of the analyte 40 to be detected have been deposited upon the sample pad 21. The analyte 40, which is fluidized, moves in the direction of the arrow shown in FIG. 1A from one end of the membrane to the other.
  • [0034]
    [0034]FIG. 1A shows a schematic view in which the components of the assay 20 are enlarged for purposes of explanation. FIG. 1A shows membrane 23 at a point when the test sample or test solution has been applied to the sample pad 21 for only a short period of time. Probes 41 are seen upon the conjugate pad 22. Typically, probes 41 are dried or immobilized upon the conjugate pad 22. Probe conjugate 42 also is immobilized upon the conjugate pad 22. Once molecules of analyte 40 bind with probe conjugates 41-42, they become probe conjugate analyte complexes (such as probe analyte conjugate complex 49-50 shown in FIG. 1B) which are mobile along the membrane 23.
  • [0035]
    The detection zone 24 is shown in FIG. 1A having several capture reagents 43 a-c immobilized upon the detection zone 44. These capture reagents 43 a-c serve as stationary binding sites for the probe analyte conjugate complexes 49-50 which migrate to them, as further shown in FIG. 1B. The chemical identity of capture reagents 43 a-c is further described herein.
  • [0036]
    The calibration zone 32 is shown near the end of the membrane 23. The calibration zone 32 provides at least two or more control lines, shown in this particular example as control lines 25-27. In many cases, the control lines are provided with a “binder” which is used to bind probe 41 molecules which pass the length of the membrane 23. The “binder” may include an antibody, such as second antibody 47 a-c shown in FIG. 1B. The control lines 25-27 have a certain and specific amount of second antibody 47 a-c provided thereon, so that in a saturated environment having large amounts of probe 41 or probe conjugate 42, they will reveal a specific, exact, and predetermined level of signal intensity. It will be recognized that thousands of molecules are provided upon the membrane 23, but the FIGS. 1A-1B show only a few molecules, for purposes of illustration.
  • [0037]
    [0037]FIG. 1B shows the membrane 23 of FIG. 1A at a later point in time after the solution has migrated as shown in the arrow of FIG. 1B. A probe conjugate complex 49 and a probe conjugate complex 50 may be seen migrating from the conjugate pad 22 to the detection zone 44. Several sandwich complexes 45 a, b and c have formed by the union of probe conjugate complexes similar to that shown as probe conjugate complex 49 with capture reagent 43 a-c (FIG. 1A), forming an immobilized sandwich complex 45 a-c within the detection zone.
  • [0038]
    Probes 41 and probe conjugates 42 which are not bound to analyte, also become mobile through the detection line 24 (see for example probe 52), and continue beyond the detection line 24 to the calibration zone 32. The calibration zone 32 includes calibration lines 25, 26, and 27. The calibration lines 25-27 may be pre-loaded upon the membrane 23 with a second capture reagent, such as second antibody 47, and thus an intensity of color is generated upon the calibration lines 25-27 upon migration of probe 41 or probe conjugates 42. A control probe complex 56 may be formed when a probe 41 attaches. Likewise, a control probe conjugate complex 57 may be formed by attachment of a probe conjugate 42. Both probes 41 and probe conjugates 42 are available for binding in the detection zone 32.
  • [0039]
    An excess of probe molecules, such as dyed microparticles, can be employed in the assay 20, so that each calibration line 25-27 reaches its full and predetermined potential for signal intensity. That is, the amount of probe 41 molecules that are deposited upon calibration lines 25-27 are predetermined because the amount of capture reagent employed on the calibration lines 25-27 is set at a predetermined and known level. A comparison may be made between the intensity levels of the calibration lines 25-27 and the detection line 24 to calculate the amount of analyte 40 present in the sample or solution. This comparison step may occur visually, or with the aid of a reading device (not shown). Wicking pad 28 receives the fluid that has migrated through membrane 23.
  • [0040]
    The membrane 23, or solid support, which is employed in the assay may be a cellulose ester. Nitrocellulose is known provides good results in some applications. It should be understood that the term “nitrocellulose” refers to nitric acid esters of cellulose, which may be nitrocellulose alone, or a mixed ester of nitric acid and other acids, in particular, aliphatic carboxylic acids having from one to seven carbon atoms.
  • [0041]
    Although nitrocellulose may be a suitable material for producing the membrane, it is to be understood that other materials may also be employed for such solid supports including but not limited to nylon, rayon, and the like.
  • [0042]
    In accordance with a particular preferred embodiment, the pore size of the solid support is such that the probe, when bound to the analyte remains on the surface of the membrane 23. Thus, for example, good results have been obtained with nitrocellulose having a pore size of from about 0.1 to 0.5 microns.
  • [0043]
    It is to be understood that the invention can be configured for detecting a broad range of analytes, including therapeutic drugs, drugs of abuse, hormones, vitamins, proteins (including antibodies of all classes), peptides, steroids, bacteria, viruses, parasites, components or products of bacteria, fungi, allergens of all types, antigens of all types, products or components of normal or malignant cells, and the like.
  • [0044]
    The following analytes are examples of analytes that may be tested using the present invention: T.sub.4, T.sub.3, digoxin, hCG, insulin, theophylline, luteinizing hormone, organisms causing or associated with various disease states, such as streptococcus pyogenes (group A), Herpes Simplex I and II, cytomegalovirus, chlamydiae, and others known in the art.
  • [0045]
    U.S. Pat. No. 4,366,241 (Tom et al.) lists at columns 19-26 a variety of potential analytes of interest that are members of an immunologic pair, including proteins, blood clofting factors, hormones, microorganisms, pharmaceutical agents, and vitamins. Any of these analytes are suitable for use as the analyte in present invention.
  • [0046]
    Other examples of preferred ligands or analytes that may be detected include the following: human bone alkaline phosphatase antigen (HBAPAg); human chorionic gonadotropin (hCG); human luteinizing hormone (hLH); human follicle stimulating hormone (hFSH); creatine phosphokinase MB isoenzyme; ferritin; carcinoembryonic antigen (CEA); prostate specific antigen (PSA); CA-549 (a breast cancer antigen); hepatitis B surface antigen (HBsAg); hepatitis B surface antibody (HBsAb); hepatitis B core antigen (HBcAg); hepatitis B core antibody (HBcAb); hepatitis A virus antibody; an antigen of human immunodeficiency virus HIV I, such as gp 120, p66, p41, p31, p24 or p17; the p41 antigen of HIV II; and the respective antiligand (preferably a monoclonal antibody) to any one of the above ligands. The HIV antigens are described more fully in U.S. Pat. No. 5,120,662 and in Gelderblood et al., Virology 156:171-176 1987, both of which are incorporated herein by reference.
  • [0047]
    As used herein, the term “probe-conjugate” refers to a species that is capable of carrying an analyte in a lateral flow assay to form a probe conjugate complex, which binds with a first capture reagent in the detection zone 24 to become a “sandwich complex” in detection area or detection zone 24.
  • [0048]
    As used herein, the term “microparticle” is a more specific reference to a particular type of probe, and may include any beads or probes to which an antibody may be bound, whether covalently, or non-covalently such as by adsorption. An additional requirement for some particles that are used in a quantitative assay is that the particle contributes a signal, usually light absorption, which would cause the zone in which the particles were located to have a different signal than the rest of the membrane 23.
  • [0049]
    The microparticle employed typically must be capable of being retained by the membrane 23. For example, when a microparticle is subject to liquid flow, the microparticle must be capable of remaining substantially immobilized. The microparticles may be of any shape but are preferably spherical. The nature of the microparticle may vary widely. It may be naturally occurring or synthetic. It can be a single material, a few materials, or a combination of a wide variety of materials. Naturally occurring microparticles include nuclei, mycoplasma, plasmids, plastids, mammalian cells (e.g., erythrocyte ghosts), unicellular microorganisms (e.g., bacteria) and the like. Synthetic microparticles may be prepared from synthetic or naturally occurring materials, or combinations thereof.
  • [0050]
    For example, latex microparticles may be prepared from a synthetic material such as styrene. Other microparticles may be prepared from naturally occurring materials, such as polysaccharides, e.g., agarose, or the like. (See, e.g., Gould, et al., U.S. Pat. No. 4,837,168, which describes the use of a variety of particles.) Preferred microparticles are microspheres of latex (i.e., a natural or a synthetic polymer) or glass; more preferably microspheres of latex. The microspheres of glass or latex are also referred to in the art as “beads” or “microbeads.”
  • [0051]
    A typical size for such beads is about 0.3 microns, but the invention may employ microparticles having greater or lesser size. For example, the mean diameter for the microparticle component of the present invention is within the range from about 0.01 microns to about 100 microns and more typically from about 0.1 microns to about 75 microns. The mean diameter and type of the microparticle chosen for a particular application will depend upon the pore size of the membrane and/or its composition.
  • [0052]
    Latex microparticles for use in the present invention are commercially available as polymeric microspheres of substantially uniform diameter (hereinafter “polymeric microspheres”), such as from Bangs Laboratories of Carmel, Ind., or Dow Chemical Co. of Midland, Mich. Although any polymeric microsphere that is capable of adsorbing or of being covalently bound to a binding partner may be used in the present invention, the polymeric microspheres typically are composed of one or more members of the group consisting of polystyrene, butadiene styrenes, styreneacrylic-vinyl terpolymer, polymethylmethacrylate, polyethylmethacrylate, styrene-maleic anhydride copolymer, polyvinyl acetate, polyvinylpyridine, polydivinylbenzene, polybutyleneterephthalate, acrylonitrile, vinylchloride-acrylates and the like or an aldehyde, carboxyl, amino, hydroxyl, or hydrazide derivative thereof.
  • [0053]
    The underivatized polymeric microspheres, such as polystyrene, are hydrophobic and passively adsorb other hydrophobic molecules, including most proteins and antibodies. Techniques for adsorbing a protein or polypeptide on a hydrophobic particle are provided in the publication by Cantarero, et al. “The Absorption Characteristics of Proteins for Polystyrene and Their Significance in Solid Phase Immunoassays,” Analytical Biochemistry 105, 375-382 (1980); and Bangs, “Latex Immunoassays,” J. Clin. Immunoassay, 13 127-131 (1980) both of which are incorporated herein by reference.
  • [0054]
    Various procedures for adsorbing molecules on polymeric microspheres are also described, in general terms, in Bangs, L. B., “Uniform Latex Particles,” presented at a workshop at the 41st National Meeting, Amer. Assoc. Clin. Chem., 1989, and available in printed form from Seragen Diagnostics Inc., Indianapolis, Ind.; or Galloway, R. J., “Development of Microparticle Tests and Immunoassays,” i.e., Seradyn Inc. of Indiana which is incorporated herein by reference.
  • [0055]
    The covalent bonding of a binding partner to a microparticle may be accomplished either directly, such as by reacting an activated chemical functional group on the surface of a microparticle with an appropriate chemical functional group on the binding partner, or indirectly, such as by covalently binding the binding partner to a spacer molecule that has been covalently bound to the surface of the microparticle.
  • [0056]
    By the phrase “membrane” as used herein is meant a test device that employs a membrane and one or more reagents to detect the concentration of an analyte of interest in a test solution, preferably an aqueous test solution. At least one of the reagents associated with the membrane device is a binding partner of the analyte of interest.
  • [0057]
    The calibration device and method of the present invention is useful with essentially any membrane-based devices. A particularly preferred use for the calibrator of the present invention is as an internal calibrator. The choice and size of a microparticle for the stabilized internal calibrator of a membrane-based device is influenced by the choice of material for the membrane. The internal calibrator of the present invention may be affixed to the membrane by covalent or non-covalent bonding.
  • [0058]
    In the practice of the invention, calibration and sample testing may be conducted under essentially exactly the same conditions at the same time, thus providing reliable quantitative results, with increased sensitivity.
  • [0059]
    The invention also may be employed for semi-quantitative detection. As the multiple control lines provide a range of signal intensities, the signal intensity of a given detection line can be compared (i.e. such as for example, visually) with the intensity of the control lines. Based upon the intensity range wherein the detection line falls, the possible concentration range for the analyte may be determined. The probes may be latex beads labeled with any signal generating species or the labeled latex beads further conjugated with antibodies.
  • [0060]
    The signal ratio between the detection lines and the control lines may be plotted against the analyte concentrations for a range of analyte concentrations to generate a calibration curve, such as shown in FIG. 2 herein. To determine the quantity of an unknown sample, the signal ratio may be converted to analyte concentration according to the calibration curve.
  • EXAMPLE 1
  • [0061]
    Polyethyleneimine was used to demonstrate the invention. A 7.4% polyethyleneimine aqueous solution (stock solution)(1×), a 10× dilution and a 100× dilution were stripped onto Millipore SX membrane to form three control lines. The membrane was dried for about 1 hour at about 37 degrees Centigrade. A wicking pad was attached upon one end of the membrane. The other end of the membrane was inserted into a suspension of blue latex beads or red fluorescent latex beads containing 1.6% Tween 20 (a surfactant) or antibody-conjugated latex beads with 1.6% Tween 20. Five minutes later, the beads were captured on the lines where the polyethyleneimine solution was stripped.
  • EXAMPLE 2
  • [0062]
    In another example, the membrane was stripped with three different polyethyleneimine solutions (1×, 10×, 100− dilution) on the lines of the calibration zone 32 and anti C-reactive protein (CRP) monoclonal antibody (Mab A5804) was immobilized on the detection zone. The membrane was dried for about one hour at about 37 degrees Centigrade, and the wicking pad was attached to the end of the membrane to form a half dipstick. The other end of the half dipstick was inserted into a solution with CRP antigen and anti CRP monoclonal antibody (Mab A5801 1) conjugated to latex particles (blue). The solution flowed through the detection and control zones, and then to the wicking pad. One blue line on the detection zone and three blue lines on the control zone were observed.
  • [0063]
    In the above examples, it was observed that the signal intensities of the control lines were significantly different. The control line stripped with 7.4% polyethyleneimine stock solution exhibited the most signal intensity while the control line stripped with 100× dilution solution exhibited the least signal intensity. This observation was true for blue colored and red fluorescent latex beads alone, as well as these beads further conjugated with antibodies.
  • EXAMPLE 3
  • [0064]
    The membrane HF 09002 was stripped with 0.14% (calibration #1), 0.64% (calibration #2) and 1.4% (calibration #3) of polyethyleneimine solution on the calibration or calibration zone 32. On the detection line 24, anti CRP monoclonal antibody at 1 mg/ml (Mab A5804) was immobilized. The membrane was dried at 37° C. for one hour and the wicking pad 28 was attached to the end of the membrane to form the half stick. The half sticks were inserted into the solutions containing the following nano-grams of CRP antigen (0. 0.54, 5.4 and 54) with excess amount of blue latex beads which are conjugated with anti CRP monoclonal antibody (Mab58011). It was observed that three calibration lines were formed with different intensities, where the line had 1.4% polyethyleneimine concentration exhibits the highest line intensity and the line had 0.14% polyethyleneimine concentration had the least line intensity. The same experiments were carried out with a mixture of blue latex beads and latex beads antibody conjugate and the same results were observed. (Experiments with different polyelectrolytes were also carried out, such that line 1, 2 and 3 may be totally different polymers).
  • [0065]
    Results from Example 3 are provided below in Table 1.
    TABLE 1
    Signal Intensities of Calibration and Detection Lines
    Calibration #1 A A A A
    Calibration #2 B B B B
    Calibration #3 C C C C
    Detection None (0 ng) C (0.54 ng) B (5.4 ng) A (54 ng)
    Line
  • [0066]
    The results indicated that the intensity of calibration line #3 represents 0.54 ng of analyte, calibration line #2 represents 5.4 ng of analyte, and calibration line #1 represents 54 ng of analyte. When an unknown sample was tested, the analyte concentration could be visually determined by comparing the detection line intensity with the three calibration lines.
  • [0067]
    When the detection line intensity was less than calibration line #3, the concentration of the analyte was determined to be less than about 0.54 ng. When the detection line intensity was visually determined to be between calibration line #3 and #2, the analyte concentration was found to be between 0.54 and 5.4 ng. When the detection line intensity was found to be higher than calibration line #3, the analyte concentration was determined to be higher than 54 ng.
  • EXAMPLE 4
  • [0068]
    The same procedure as Example 3 was conducted, with the exception that the concentration of the analyte was quantified by a electronic reading device. In such diagnostic reading devices, electronic routines make it possible to read automatically the intensities of calibration and detection lines and provide a readout or display for the analyte concentration.
  • [0069]
    The latex beads generate a detectable colored light signal, from both the detection zone 31 and the control lines of the calibration zone 32. The reading device provides a comparison means for comparing the intensity of colored light signals generated by latex beads positioned upon the control lines 25-27 with the intensity of signals generated by microparticle-analyte conjugates positioned upon the detection zone 31.
  • EXAMPLE 5
  • [0070]
    In yet another application of the invention, it is possible to use fluorescence to determine the amount of analyte in a test sample. In this manner, it is possible to use a probe or a microparticle which itself is capable of exhibiting the property of fluorescence, in which signals are generated from the probe or microparticle once it has been deposited in either the calibration zone 32 or the detection zone 31. A receiver or a receiving device is capable of measuring the amount of signal generated in the detection zone 31 and the calibration zone 32, and making the appropriate comparisons to determine the quantity of analyte in a given test sample.
  • [0071]
    It is understood by one of ordinary skill in the art that the present discussion is a description of exemplary embodiments only, and is not intended as limiting the broader aspects of the present invention, which broader aspects are embodied in the exemplary constructions. The invention is shown by example in the appended claims.

Claims (22)

    What is claimed is:
  1. 1. A lateral flow assay for detecting the quantity of analyte residing in a test solution, the assay comprising:
    (a) a plurality of probes, the probes being configured for generating a detectable signal, wherein the probes are capable of combining with analyte to form a probe conjugate analyte complex;
    (b) a membrane, the membrane being configured for mobilizing a test solution containing both probes and probe conjugate analyte complexes, the membrane comprising:
    (i) a detection zone, the detection zone having deposited thereon an immobilized first capture reagent, wherein the immobilized first capture reagent is configured for bonding with probe-conjugate analyte complexes to form sandwich complexes that generate signals;
    (ii) a calibration zone, the calibration zone comprising at least first and second control lines, wherein the first and second control lines each have applied thereon a predetermined amount of a second capture reagent, the second capture reagent being configured to immobilize probes upon the first and second control lines to form control probe complexes capable of generating a control signal.
  2. 2. The lateral flow assay of claim 1, further comprising:
    (c) a comparison means for comparing the intensity of signals generated by control probe complexes positioned upon said first and second control lines with the intensity of signals generated by sandwich complexes positioned upon the detection zone.
  3. 3. The lateral flow assay of claim 2, further wherein a calibration curve is generated using signal intensity data generated by control probe complexes positioned upon the control lines.
  4. 4. The lateral flow assay of claim 1 in which the probe comprises a microparticle that is capable of generating a visual signal.
  5. 5. The lateral flow assay of claim 4 in which the microparticle is capable of generating a color intensity.
  6. 6. The lateral flow assay of claim 1 in which the probe is capable of generating a fluorescent signal.
  7. 7. The lateral flow assay of claim 1 in which the probe comprises a microparticle.
  8. 8. The lateral flow assay of claim 7 in which the microparticle exhibits a color intensity.
  9. 9. The lateral flow assay of claim 2 in which a detection device is provided for detecting signals generated by control probe complexes positioned upon respective control lines with the intensity of signals generated by sandwich complexes positioned upon the detection zone.
  10. 10. The lateral flow assay of claim 2 wherein the probe comprises a microparticle, further wherein the comparison means comprises a device adapted for comparing intensity of light signals generated from the first and second control lines with the intensity of signals generated by sandwich complexes positioned upon the detection zone.
  11. 11. The lateral flow assay of claim 10, further wherein a calibration curve is generated using signal intensity data from the first and second control lines.
  12. 12. The lateral flow assay of claim 11 in which an automated system of generating the curve and performing the comparison is provided.
  13. 13. A method of detecting the quantity of an analyte present in a test solution, the method comprising:
    (a) providing a membrane with a test solution containing analyte;
    (b) providing a plurality of probes and probe conjugates upon the membrane;
    (c) binding the probe conjugates with the analyte to form probe analyte conjugates;
    (d) wherein the membrane comprises a first end and a second end, the membrane having a first capture reagent immobilized upon a detection zone, the membrane being configured for mobilizing a test solution containing probe-analyte conjugates from the first end to the second end of the membrane;
    (e) capturing within a detection zone probe-analyte conjugates, thereby forming immobilized signal generating sandwich complexes within the detection zone;
    (f) providing a calibration zone upon the membrane, the calibration zone comprising at least first and second control lines having predetermined amounts of a second capture reagent immobilized upon said control lines;
    (g) capturing, with the second capture reagent, probes upon the first and second control lines by forming control probe complexes upon said control lines;
    (h) generating a first set of control signals from the control probe complexes;
    (i) generating a second set of measured signals from the sandwich complexes in the detection zone; and
    (j) comparing the control signals to the measured signals to determine the quantity of analyte present in the test solution.
  14. 14. The method of claim 14, wherein prior to step (j), the method further comprises the step of generating a signal intensity curve, further wherein step (j) comprises comparing control signals to the signal intensity curve to provide a determination of the quantity of analyte present in a test solution.
  15. 15. The method of claim 14 in which the probe comprises a microparticle that is capable of generating a signal.
  16. 16. The method of claim 15 in which the microparticle is capable of generating a color intensity.
  17. 17. The method of claim 16 in which the microparticle is a latex bead.
  18. 18. The method of claim 14 in which the probe is capable of generating a fluorescent signal.
  19. 19. The method of claim 13 in which a third control line is employed.
  20. 20. The method of claim 19 in which a fourth control line is employed.
  21. 21. The method of claim 19 in which the probes comprise latex beads.
  22. 22. The method of claim 21 in which latex beads further include coloring agents for providing a visually detectable signal.
US10035014 2001-12-24 2001-12-24 Lateral flow assay devices and methods for conducting assays Abandoned US20030119203A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10035014 US20030119203A1 (en) 2001-12-24 2001-12-24 Lateral flow assay devices and methods for conducting assays

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US10035014 US20030119203A1 (en) 2001-12-24 2001-12-24 Lateral flow assay devices and methods for conducting assays
US10132673 US20030119204A1 (en) 2001-12-24 2002-04-25 Internal calibration system for flow-through assays
US10132421 US7651841B2 (en) 2001-12-24 2002-04-25 Polyelectrolytic internal calibration system of a flow-through assay
KR20047009945A KR101043888B1 (en) 2001-12-24 2002-11-21 Internal calibration system for flow-through assays
RU2004122925A RU2004122925A (en) 2001-12-24 2002-11-21 The system of internal calibration of the flow test systems
EP20020806133 EP1459068B1 (en) 2001-12-24 2002-11-21 Internal calibration system for flow-through assays
DE2002637395 DE60237395D1 (en) 2001-12-24 2002-11-21 Internal calibration system for flow tests
CA 2471462 CA2471462C (en) 2001-12-24 2002-11-21 Internal calibration system for flow-through assays
CN 02825950 CN100501406C (en) 2001-12-24 2002-11-21 Internal calibration system for flow-through assays
PCT/US2002/037653 WO2003058246A1 (en) 2001-12-24 2002-11-21 Flow-through assay with an internal calibration system using polyelectrolyte
PCT/US2002/037652 WO2003058242A3 (en) 2001-12-24 2002-11-21 Internal calibration system for flow-through assays
US12616821 US8137985B2 (en) 2001-12-24 2009-11-12 Polyelectrolytic internal calibration system of a flow-through assay

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10132673 Continuation-In-Part US20030119204A1 (en) 2001-12-24 2002-04-25 Internal calibration system for flow-through assays
US10132421 Continuation-In-Part US7651841B2 (en) 2001-12-24 2002-04-25 Polyelectrolytic internal calibration system of a flow-through assay
US10134421 Continuation-In-Part US6837171B1 (en) 2002-04-29 2002-04-29 Lightweight table with unitized table top

Publications (1)

Publication Number Publication Date
US20030119203A1 true true US20030119203A1 (en) 2003-06-26

Family

ID=21880091

Family Applications (3)

Application Number Title Priority Date Filing Date
US10035014 Abandoned US20030119203A1 (en) 2001-12-24 2001-12-24 Lateral flow assay devices and methods for conducting assays
US10132421 Active 2024-11-22 US7651841B2 (en) 2001-12-24 2002-04-25 Polyelectrolytic internal calibration system of a flow-through assay
US10132673 Abandoned US20030119204A1 (en) 2001-12-24 2002-04-25 Internal calibration system for flow-through assays

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10132421 Active 2024-11-22 US7651841B2 (en) 2001-12-24 2002-04-25 Polyelectrolytic internal calibration system of a flow-through assay
US10132673 Abandoned US20030119204A1 (en) 2001-12-24 2002-04-25 Internal calibration system for flow-through assays

Country Status (3)

Country Link
US (3) US20030119203A1 (en)
KR (1) KR101043888B1 (en)
DE (1) DE60237395D1 (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092036A1 (en) * 2002-09-11 2004-05-13 Lattec I/S Device for analysing analyte compounds and use hereof
WO2005057216A1 (en) * 2003-11-21 2005-06-23 Kimberly-Clark Worldwide, Inc. Method of reducing the sensitivity of assay devices
US20050221505A1 (en) * 2004-04-01 2005-10-06 Petruno Patrick T Optoelectronic rapid diagnostic test system
WO2006003394A1 (en) * 2004-07-01 2006-01-12 Central Science Laboratory (Csl) Representing The Secretary Of State For Environment, Food And Rural Affairs Analyte detection system
US20060240541A1 (en) * 2005-04-22 2006-10-26 Petruno Patrick T Lateral flow assay systems and methods
US20060286616A1 (en) * 2005-03-22 2006-12-21 Miki Furukawa Menopause stage monitor
WO2007053487A2 (en) * 2005-10-28 2007-05-10 Binax, Inc. Methods and devices for detection of the strain of a pathogen
US20070116595A1 (en) * 2005-11-22 2007-05-24 Petrilla John F Assaying test strips having different capture reagents
US20070122914A1 (en) * 2005-11-30 2007-05-31 Curry Bo U Obtaining measurements of light transmitted through an assay test strip
US20070161078A1 (en) * 2005-07-01 2007-07-12 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
US20070185679A1 (en) * 2004-04-01 2007-08-09 Petruno Patrick T Indicating status of a diagnostic test system
US20070188736A1 (en) * 2006-02-16 2007-08-16 Fouquet Julie E Obtaining measurement and baseline signals for evaluating assay test strips
US20070224594A1 (en) * 2005-07-01 2007-09-27 Arbor Vita Corporation Detection of influenza virus
US20070231922A1 (en) * 2004-04-01 2007-10-04 Petruno Patrick T Assay test strips with multiple labels and reading same
US20080028261A1 (en) * 2005-12-19 2008-01-31 Petruno Patrick T End-of-life disabling of a diagnostic test system
US7410808B1 (en) 2003-12-08 2008-08-12 Charm Sciences, Inc. Method and assay for detection of residues
US20090180928A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips with multiple labels and reading same
EP2180319A1 (en) * 2008-10-21 2010-04-28 Kaiwood Technology Co., Ltd. Biological test strip
US20100167264A1 (en) * 2008-12-30 2010-07-01 Jin Po Lee Quantitative analyte assay device and method
US20100175455A1 (en) * 2009-01-14 2010-07-15 Alverix, Inc. Methods and materials for calibration of a reader
WO2011020724A1 (en) * 2009-08-17 2011-02-24 Dst Diagnostische Systeme & Technologien Gmbh Test system for visual analysis
US20110097820A1 (en) * 2003-12-23 2011-04-28 Kimberly-Clark Worldwide, Inc. Swab-Based Diagnostic Systems
EP2325640A1 (en) * 2008-08-22 2011-05-25 DENKA SEIKEN Co., Ltd. Test apparatus for membrane assay equipped with reference display section
US20110171754A1 (en) * 2007-09-14 2011-07-14 Gareth Redmond Analysis system
WO2011110734A1 (en) * 2010-03-09 2011-09-15 Nokia Corporation Apparatus for analyte sensing and associated methods
US20110244598A1 (en) * 2008-12-03 2011-10-06 Roche Diagnostics Operations, Inc. Test Element Having Combined Control and Calibration Zone
WO2011124991A3 (en) * 2010-04-07 2011-12-29 Biosensia Patents Limited Flow control device for assays
CN102539769A (en) * 2011-12-22 2012-07-04 正元盛邦(天津)生物科技有限公司 Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography
US20120171702A1 (en) * 2009-06-30 2012-07-05 Monash University Quantitative and self-calibrating chemical analysis using paper-based microfluidic systems
JP4988546B2 (en) * 2005-01-28 2012-08-01 持田製薬株式会社 Immunochromatographic test device and a semi-quantitative method using the same
US20120225422A1 (en) * 2011-03-03 2012-09-06 RoMonics, LLC Method and device employing a non-receptor ligand interaction with nanoparticles or other solid phase followed by specific detection
USD667228S1 (en) 2009-09-24 2012-09-18 Yuyama Manufacturing Co., Ltd. Sheet for a drug bag
US8900881B2 (en) 2008-12-30 2014-12-02 Jin Po Lee Quantitative analyte assay device and method
CN104937418A (en) * 2012-11-15 2015-09-23 奥索临床诊断有限公司 Calibrating assays using reaction time
WO2017112780A1 (en) * 2015-12-22 2017-06-29 Polymer Technology Systems, Inc. Systems and methods for quantification of creatinine using a creatinine-protein conjugate

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6837171B1 (en) 2002-04-29 2005-01-04 Palmer/Snyder Furniture Company Lightweight table with unitized table top
EP1504263A1 (en) * 2002-05-13 2005-02-09 Peter Asberg Polyelectrolyte complex (e.g.zwitterionic polythiophenes) with a receptor (e.g. polynucleotide, antibody etc.) for biosensor applications
US7285424B2 (en) * 2002-08-27 2007-10-23 Kimberly-Clark Worldwide, Inc. Membrane-based assay devices
US7640083B2 (en) * 2002-11-22 2009-12-29 Monroe David A Record and playback system for aircraft
US7247500B2 (en) 2002-12-19 2007-07-24 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in membrane-based assay devices
US20050112703A1 (en) 2003-11-21 2005-05-26 Kimberly-Clark Worldwide, Inc. Membrane-based lateral flow assay devices that utilize phosphorescent detection
US7943395B2 (en) 2003-11-21 2011-05-17 Kimberly-Clark Worldwide, Inc. Extension of the dynamic detection range of assay devices
US7943089B2 (en) 2003-12-19 2011-05-17 Kimberly-Clark Worldwide, Inc. Laminated assay devices
GB0403369D0 (en) * 2004-02-16 2004-03-17 Pa Consulting Services Devices and methods for testing analytes
US20050244953A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Techniques for controlling the optical properties of assay devices
US7796266B2 (en) 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US7815854B2 (en) * 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US20060019265A1 (en) * 2004-04-30 2006-01-26 Kimberly-Clark Worldwide, Inc. Transmission-based luminescent detection systems
DE102004023402A1 (en) * 2004-05-12 2005-12-08 Roche Diagnostics Gmbh A method for increasing the dynamic measuring range of on specific binding reactions based, in particular immunological test elements
US7906276B2 (en) 2004-06-30 2011-03-15 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
US7094528B2 (en) * 2004-06-30 2006-08-22 Kimberly-Clark Worldwide, Inc. Magnetic enzyme detection techniques
US7521226B2 (en) 2004-06-30 2009-04-21 Kimberly-Clark Worldwide, Inc. One-step enzymatic and amine detection technique
CA2588230A1 (en) * 2004-11-23 2006-08-10 Response Biomedical Corporation Immunoassay employing two-step internal calibration reaction
US7682817B2 (en) * 2004-12-23 2010-03-23 Kimberly-Clark Worldwide, Inc. Microfluidic assay devices
US7939342B2 (en) 2005-03-30 2011-05-10 Kimberly-Clark Worldwide, Inc. Diagnostic test kits employing an internal calibration system
US7803319B2 (en) * 2005-04-29 2010-09-28 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
US7858384B2 (en) * 2005-04-29 2010-12-28 Kimberly-Clark Worldwide, Inc. Flow control technique for assay devices
JP2009506319A (en) * 2005-08-23 2009-02-12 レスポンス バイオメディカル コーポレーション Multilateral immunochromatographic assay
US7504235B2 (en) 2005-08-31 2009-03-17 Kimberly-Clark Worldwide, Inc. Enzyme detection technique
US7829347B2 (en) 2005-08-31 2010-11-09 Kimberly-Clark Worldwide, Inc. Diagnostic test kits with improved detection accuracy
US8003399B2 (en) 2005-08-31 2011-08-23 Kimberly-Clark Worldwide, Inc. Nitrite detection technique
US7279136B2 (en) 2005-12-13 2007-10-09 Takeuchi James M Metering technique for lateral flow assay devices
US7745158B2 (en) 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
US7618810B2 (en) * 2005-12-14 2009-11-17 Kimberly-Clark Worldwide, Inc. Metering strip and method for lateral flow assay devices
US20120269728A1 (en) * 2006-08-02 2012-10-25 Antara Biosciences Inc. Methods and compositions for detecting one or more target agents using tracking components
US8460878B2 (en) * 2006-02-21 2013-06-11 The Trustees Of Tufts College Methods and arrays for detecting cells and cellular components in small defined volumes
US8758989B2 (en) * 2006-04-06 2014-06-24 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
JP2009543076A (en) * 2006-07-11 2009-12-03 ブロックウェル,ポール ナイジェルBROCKWELL,Paul Nigel Indicator system for measuring an analyte concentration
US8044257B2 (en) 2006-10-30 2011-10-25 Kimberly-Clark Worldwide, Inc. Absorbent article containing lateral flow assay device
US8012761B2 (en) * 2006-12-14 2011-09-06 Kimberly-Clark Worldwide, Inc. Detection of formaldehyde in urine samples
US7897360B2 (en) 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
US7935538B2 (en) * 2006-12-15 2011-05-03 Kimberly-Clark Worldwide, Inc. Indicator immobilization on assay devices
US7846383B2 (en) * 2006-12-15 2010-12-07 Kimberly-Clark Worldwide, Inc. Lateral flow assay device and absorbent article containing same
US20080269707A1 (en) 2007-04-30 2008-10-30 Kimberly-Clark Worldwide, Inc. Lateral Flow Device for Attachment to an Absorbent Article
US8043272B2 (en) 2007-04-30 2011-10-25 Kimberly-Clark Worldwide, Inc. Collection and testing of infant urine using an absorbent article
CA2734029C (en) 2007-08-30 2016-03-29 The Trustees Of Tufts College Methods for determining the concentration of an analyte in solution
US8535617B2 (en) * 2007-11-30 2013-09-17 Kimberly-Clark Worldwide, Inc. Blood cell barrier for a lateral flow device
US8222047B2 (en) * 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
US20100290948A1 (en) * 2009-05-15 2010-11-18 Xuedong Song Absorbent articles capable of indicating the presence of urinary tract infections
US8900850B2 (en) * 2009-09-17 2014-12-02 Michael J. Lane Lateral flow based methods and assays for rapid and inexpensive diagnostic tests
US8415171B2 (en) * 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
EP2542890B1 (en) 2010-03-01 2015-05-06 Quanterix Corporation Methods for extending dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
CN101900728A (en) * 2010-08-05 2010-12-01 中国农业科学院油料作物研究所 Multi-test-line immunochromatographic test strip for semi-quantitatively detecting aflatoxin B1 and preparation method thereof
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
US9524372B2 (en) * 2011-09-09 2016-12-20 Alverix, Inc. In-vitro diagnostic device using external information in conjunction with test results
US9715579B2 (en) * 2011-09-09 2017-07-25 Alverix, Inc. Distributed network of in-vitro diagnostic devices
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
JP6300676B2 (en) * 2014-07-30 2018-03-28 株式会社日立ハイテクノロジーズ Analysis method and an automatic analyzer
JP6312555B2 (en) * 2014-08-14 2018-04-18 デンカ生研株式会社 Methods for extending the range of quantification in immunochromatography

Family Cites Families (379)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55776A (en) * 1866-06-19 Improvement in tree-protectors
US14073A (en) * 1856-01-08 Improvement in seeding-machines
US146754A (en) * 1874-01-27 Improvement in harness-names
US164659A (en) 1875-06-22 Improvement in processes of preparing pickles
US17615A (en) * 1857-06-23 Printing-press
US450854A (en) * 1891-04-21 Adolf weidenbusch
US3772076A (en) 1970-01-26 1973-11-13 Hercules Inc Reaction products of epihalohydrin and polymers of diallylamine and their use in paper
US3700623A (en) 1970-04-22 1972-10-24 Hercules Inc Reaction products of epihalohydrin and polymers of diallylamine and their use in paper
GB1513939A (en) 1974-11-26 1978-06-14 Ceskoslovenska Akademie Ved Method of manufacturing spherical polymer particles from polymer solutions
NL7600128A (en) 1975-01-27 1976-07-29 Kabi Ab Diagnostic agents, and a method for immuno-chemical determination.
USRE30267E (en) 1975-06-20 1980-05-06 Eastman Kodak Company Multilayer analytical element
US4094647A (en) * 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
US4210723A (en) 1976-07-23 1980-07-01 The Dow Chemical Company Method of coupling a protein to an epoxylated latex
US4115535A (en) 1977-06-22 1978-09-19 General Electric Company Diagnostic method employing a mixture of normally separable protein-coated particles
US4374925A (en) * 1978-11-24 1983-02-22 Syva Company Macromolecular environment control in specific receptor assays
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4235601A (en) 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4361537A (en) 1979-01-12 1982-11-30 Thyroid Diagnostics, Inc. Test device and method for its use
US4441373A (en) * 1979-02-21 1984-04-10 American Hospital Supply Corporation Collection tube for drawing samples of biological fluids
US4312228A (en) * 1979-07-30 1982-01-26 Henry Wohltjen Methods of detection with surface acoustic wave and apparati therefor
US4540659A (en) 1981-04-17 1985-09-10 Syva Company Simultaneous calibration heterogeneous immunoassay
US5156953A (en) 1979-12-26 1992-10-20 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4533629A (en) 1981-04-17 1985-08-06 Syva Company Simultaneous calibration heterogeneous immunoassay
US5432057A (en) 1979-12-26 1995-07-11 Syva Company Simultaneous calibration heterogeneous immunoassay
US4299916A (en) 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
FR2478086B1 (en) 1980-02-14 1982-12-03 Ciba Geigy Ag
US4427836A (en) * 1980-06-12 1984-01-24 Rohm And Haas Company Sequential heteropolymer dispersion and a particulate material obtainable therefrom, useful in coating compositions as a thickening and/or opacifying agent
EP0111762B1 (en) * 1980-06-20 1987-11-19 Unilever Plc Processes and apparatus for carrying out specific binding assays
US4366241B1 (en) 1980-08-07 1988-10-18
US4385126A (en) * 1980-11-19 1983-05-24 International Diagnostic Technology, Inc. Double tagged immunoassay
US4426451A (en) * 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4442204A (en) * 1981-04-10 1984-04-10 Miles Laboratories, Inc. Homogeneous specific binding assay device and preformed complex method
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4444592A (en) * 1981-06-02 1984-04-24 The Sherwin-Williams Company Pigment compositions and processes therefor
US4363874A (en) 1981-08-07 1982-12-14 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation nondiffusing reflecting layer
EP0073593A1 (en) 1981-09-01 1983-03-09 E.I. Du Pont De Nemours And Company Size-exclusion heterogeneous immunoassay
US4480042A (en) 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4477635A (en) 1982-01-04 1984-10-16 Minnesota Mining And Manufacturing Company Polymeric triarylmethane dyes
US4435504A (en) * 1982-07-15 1984-03-06 Syva Company Immunochromatographic assay with support having bound "MIP" and second enzyme
US4534356A (en) 1982-07-30 1985-08-13 Diamond Shamrock Chemicals Company Solid state transcutaneous blood gas sensors
US4632559A (en) 1982-11-29 1986-12-30 Miles Laboratories, Inc. Optical readhead
US4537861A (en) 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
US4537657A (en) 1983-08-26 1985-08-27 Hercules Incorporated Wet strength resins
GB8314523D0 (en) 1983-05-25 1983-06-29 Lowe C R Diagnostic device
EP0127797B1 (en) 1983-06-03 1987-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
DE3422741C2 (en) 1983-07-13 1993-07-29 Laboratoire Suisse De Recherches Horlogeres, Neuenburg/Neuchatel, Ch
US4552458A (en) 1983-10-11 1985-11-12 Eastman Kodak Company Compact reflectometer
US4595661A (en) 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
GB8406752D0 (en) * 1984-03-15 1984-04-18 Unilever Plc Chemical and clinical tests
US4743560A (en) * 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4698262A (en) 1984-04-27 1987-10-06 Becton, Dickinson And Company Fluorescently labeled microbeads
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
FI842992A0 (en) * 1984-07-26 1984-07-26 Labsystems Oy Immunologiskt definitionsfoerfarande.
US4661235A (en) * 1984-08-03 1987-04-28 Krull Ulrich J Chemo-receptive lipid based membrane transducers
US4596697A (en) * 1984-09-04 1986-06-24 The United States Of America As Represented By The Secretary Of The Army Chemical sensor matrix
US5310687A (en) * 1984-10-31 1994-05-10 Igen, Inc. Luminescent metal chelate labels and means for detection
US5026653A (en) 1985-04-02 1991-06-25 Leeco Diagnostic, Inc. Scavenger antibody mixture and its use for immunometric assay
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
CA1272127A (en) 1985-04-04 1990-07-31 Hybritech Incorporated Solid phase system for use in ligand-receptor assays
US4743542A (en) * 1985-04-11 1988-05-10 Ortho Diagnostic Method for forestalling the hook effect in a multi-ligand immunoassay system
GB8509492D0 (en) 1985-04-12 1985-05-15 Plessey Co Plc Optical assay
EP0335902B1 (en) 1986-12-15 1993-12-01 British Technology Group Usa Inc. Monomeric phthalocyanine reagents
DE3575203D1 (en) 1985-06-28 1990-02-08 Eastman Kodak Co Compact reflectometer.
US4963498A (en) 1985-08-05 1990-10-16 Biotrack Capillary flow device
US4806312A (en) * 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having detectable signal concentrating zone
US5238815A (en) 1985-08-30 1993-08-24 Toyo Soda Manufacturing Co., Ltd. Enzymatic immunoassay involving detecting fluorescence while oscillating magnetic beads
KR940002520B1 (en) 1985-10-04 1994-03-25 조셉 엠. 버닉 Solid-phase analytical device and method for using same
US5500350A (en) * 1985-10-30 1996-03-19 Celltech Limited Binding assay device
US4917503A (en) * 1985-12-02 1990-04-17 Lifelines Technology, Inc. Photoactivatable leuco base time-temperature indicator
CA1291031C (en) * 1985-12-23 1991-10-22 Jaeger Nikolaas C.J. De Method for the detection of specific binding agents and their correspondingbindable substances
US5585279A (en) 1986-01-23 1996-12-17 Davidson; Robert S. Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
US4916056A (en) * 1986-02-18 1990-04-10 Abbott Laboratories Solid-phase analytical device and method for using same
US5482830A (en) * 1986-02-25 1996-01-09 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US4776944A (en) 1986-03-20 1988-10-11 Jiri Janata Chemical selective sensors utilizing admittance modulated membranes
US5591581A (en) 1986-04-30 1997-01-07 Igen, Inc. Electrochemiluminescent rhenium moieties and methods for their use
DE3789430T2 (en) 1986-06-17 1994-10-27 Baxter Diagnostics Inc Homogeneous fluorine-testing methods with repelling the fluorine producers, background.
GB8618133D0 (en) * 1986-07-24 1986-09-03 Pa Consulting Services Biosensors
JPH0692969B2 (en) 1986-07-30 1994-11-16 徳山曹達株式会社 Immunological measurement method
US5182135A (en) * 1986-08-12 1993-01-26 Bayer Aktiengesellschaft Process for improving the adherency of metallic coatings deposited without current on plastic surfaces
US4935346A (en) 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US4867908A (en) 1986-08-29 1989-09-19 Becton, Dickinson And Company Method and materials for calibrating flow cytometers and other analysis instruments
GB8626221D0 (en) 1986-11-03 1986-12-03 Stc Plc Optical sensor device
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis
US4954435A (en) 1987-01-12 1990-09-04 Becton, Dickinson And Company Indirect colorimetric detection of an analyte in a sample using ratio of light signals
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
USRE38430E1 (en) * 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
JPH0684970B2 (en) * 1987-03-31 1994-10-26 株式会社京都医科学研究所 Occult blood detection method in feces
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
DE3887771C5 (en) * 1987-04-27 2009-06-04 Inverness Medical Switzerland Gmbh Immunoassays and devices therefor.
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
US4904583A (en) * 1987-05-26 1990-02-27 Becton, Dickinson And Company Cascade immunoassay by multiple binding reactions
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4842783A (en) 1987-09-03 1989-06-27 Cordis Corporation Method of producing fiber optic chemical sensors incorporating photocrosslinked polymer gels
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3877179D1 (en) 1987-09-24 1993-02-11 Wallac Oy Homogeneous biospecific determination method with lanthanide-marker.
US5073340A (en) 1987-10-08 1991-12-17 Becton, Dickinson And Company Depositing a binder on a solid support
US4978625A (en) 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
US5275785A (en) * 1987-10-30 1994-01-04 Unilever Patent Holdings B.V. Test device for detecting an analyte in a liquid sample
US5670381A (en) 1988-01-29 1997-09-23 Abbott Laboratories Devices for performing ion-capture binding assays
JP2763635B2 (en) 1988-02-08 1998-06-11 ウェルシュ メディカル スクール エンタープライジィス リミティド Detection of the diamine in biological fluids
US5268306A (en) 1988-02-29 1993-12-07 Boehringer Mannheim Gmbh Preparation of a solid phase matrix containing a bound specific binding pair
US5145784A (en) 1988-05-04 1992-09-08 Cambridge Biotech Corporation Double capture assay method employing a capillary flow device
EP0341928A1 (en) 1988-05-10 1989-11-15 AMERSHAM INTERNATIONAL plc Improvements relating to surface plasmon resonance sensors
DE68907519D1 (en) 1988-05-10 1993-08-19 Amersham Int Plc Biosensors.
GB8811919D0 (en) 1988-05-20 1988-06-22 Amersham Int Plc Biological sensors
US5573919A (en) 1988-06-02 1996-11-12 Carter-Wallace Assay using an absorbent material
GB8813307D0 (en) 1988-06-06 1988-07-13 Amersham Int Plc Biological sensors
EP0349215B1 (en) * 1988-06-27 1995-04-12 Carter-Wallace Inc. Method and cell for detection
US4877586A (en) 1988-07-27 1989-10-31 Eastman Kodak Company Sliding test device for assays
US5075077A (en) 1988-08-02 1991-12-24 Abbott Laboratories Test card for performing assays
US5114676A (en) * 1988-08-04 1992-05-19 Avl Ag Optical sensor for determining at least one parameter in a liquid or gaseous sample
US4973670A (en) 1988-08-12 1990-11-27 The Dow Chemical Company Method for preparing hollow latexes
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
EP0363504A1 (en) 1988-10-10 1990-04-18 Dräger Nederland B.V. Method of providing a substrate with a layer comprising a polyvinylbased hydrogel and a biochemically active material
US6448091B1 (en) 1988-11-03 2002-09-10 Igen International, Inc. Method and apparatus for improved luminescence assays using particle concentration chemiluminescence detection
WO1990005303A1 (en) 1988-11-10 1990-05-17 Pharmacia Ab Sensing surfaces capable of selective biomolecular interactions, to be used in biosensor systems
JP2814639B2 (en) 1988-11-10 1998-10-27 フアーマシア・ビオセンソル・アクチエボラーグ Its use in the sensor unit and biosensor system
DE68921635T2 (en) 1988-11-10 1995-10-05 Pharmacia Biosensor Ab Labeling of macromolecules in interaction with at least two ligands on a sensor.
US5003178A (en) * 1988-11-14 1991-03-26 Electron Vision Corporation Large-area uniform electron source
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
US5208143A (en) * 1988-11-17 1993-05-04 Becton, Dickinson And Company Immunoassay on a preblocked solid surface
US4940734A (en) 1988-11-23 1990-07-10 American Cyanamid Process for the preparation of porous polymer beads
DE68920126D1 (en) * 1988-11-23 1995-02-02 Cytec Tech Corp Porous polymer beads and procedures.
US4895017A (en) * 1989-01-23 1990-01-23 The Boeing Company Apparatus and method for early detection and identification of dilute chemical vapors
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5096671A (en) * 1989-03-15 1992-03-17 Cordis Corporation Fiber optic chemical sensors incorporating electrostatic coupling
US5120662A (en) 1989-05-09 1992-06-09 Abbott Laboratories Multilayer solid phase immunoassay support and method of use
US5234813A (en) 1989-05-17 1993-08-10 Actimed Laboratories, Inc. Method and device for metering of fluid samples and detection of analytes therein
US5770416A (en) 1989-05-26 1998-06-23 Upfront Chromatography A/S Permeable hollow particles having an outer shell of mechanically rigid porous material
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5166079A (en) 1989-07-19 1992-11-24 Pb Diagnostic Systems, Inc. Analytical assay method
JPH0366384A (en) 1989-08-04 1991-03-22 Senjiyu Seiyaku Kk System for controlling release of physiologically active material
US5235238A (en) 1989-08-10 1993-08-10 Dainabot Company, Limited Electrode-separated piezoelectric crystal oscillator and method for measurement using the electrode-separated piezoelectric crystal oscillator
EP0416587A3 (en) * 1989-09-08 1992-06-03 Terumo Kabushiki Kaisha Measuring apparatus
US5468606A (en) 1989-09-18 1995-11-21 Biostar, Inc. Devices for detection of an analyte based upon light interference
US5185127A (en) * 1989-09-21 1993-02-09 Becton, Dickinson And Company Test device including flow control means
CA2003942A1 (en) 1989-09-26 1991-03-26 Julie Lia Rudolph Solid assay support systems
JP2979414B2 (en) 1989-09-29 1999-11-15 富士レビオ株式会社 Magnetic particles, and immunoassays using the same
US5075078A (en) 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
GB8923699D0 (en) 1989-10-20 1989-12-06 Univ Strathclyde Apparatus for assessing a particular property in a medium
US5225935A (en) 1989-10-30 1993-07-06 Sharp Kabushiki Kaisha Optical device having a microlens and a process for making microlenses
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US6274324B1 (en) 1989-12-01 2001-08-14 Unilever Patent Holdings B.V. Specific binding reagent comprising a variable domain protein linked to a support or tracer
GB8927503D0 (en) 1989-12-04 1990-02-07 Kronem Systems Inc Enzyme-amplified lanthanide chelate luminescence
US5508171A (en) * 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
GB9008261D0 (en) 1990-04-11 1990-06-13 Ares Serono Res & Dev Ltd Method of improving assay sensitivity
ES2092523T3 (en) 1990-05-09 1996-12-01 Abbott Lab Assays using links conjugate recovery.
EP0745689A3 (en) 1990-05-11 1996-12-11 Microprobe Corporation A dipstick for a nucleic acid hybridization assay
DK138090D0 (en) * 1990-06-06 1990-06-06 Novo Nordisk As Diagnostic testing method
DE4024476C1 (en) 1990-08-02 1992-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim, De
GB9019123D0 (en) 1990-09-01 1990-10-17 Fisons Plc Analytical device
US5200084A (en) * 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5076094A (en) 1990-10-03 1991-12-31 The United States Of America As Represented By The United States Department Of Energy Dual output acoustic wave sensor for molecular identification
US5700636A (en) 1990-10-19 1997-12-23 Becton Dickinson And Company Methods for selectively detecting microorganisms associated with vaginal infections in complex biological samples
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US6027944A (en) * 1990-11-22 2000-02-22 Applied Research Systems Ars Holding Nv Capillary-fill biosensor device comprising a calibration zone
US5510481A (en) * 1990-11-26 1996-04-23 The Regents, University Of California Self-assembled molecular films incorporating a ligand
US5208535A (en) * 1990-12-28 1993-05-04 Research Development Corporation Of Japan Mr position detecting device
US5834226A (en) 1991-01-31 1998-11-10 Xytronyx, Inc. One-step test for aspartate aminotransferase
GB9102646D0 (en) * 1991-02-07 1991-03-27 Fisons Plc Analytical device
US5330898A (en) 1991-02-20 1994-07-19 Diagnostic Markers, Inc. Method for the very rapid detection of polyamines
US5466574A (en) 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5795470A (en) 1991-03-25 1998-08-18 Immunivest Corporation Magnetic separation apparatus
US5196350A (en) * 1991-05-29 1993-03-23 Omnigene, Inc. Ligand assay using interference modulation
EP0594766B1 (en) 1991-07-10 1999-09-08 Igen International, Inc. Methods for improved luminescence assays using particle concentration and chemiluminescence detection
US5428690A (en) 1991-09-23 1995-06-27 Becton Dickinson And Company Method and apparatus for automated assay of biological specimens
US5179288A (en) 1991-09-30 1993-01-12 Ortho Pharmaceutical Corporation Apparatus and method for measuring a bodily constituent
US5418136A (en) 1991-10-01 1995-05-23 Biostar, Inc. Devices for detection of an analyte based upon light interference
DE69223980D1 (en) * 1991-10-15 1998-02-12 Multilyte Ltd binding assay using a labeled reagent
EP0539034A1 (en) 1991-10-22 1993-04-28 Konica Corporation A novel photographic cyan coupler
US5424219A (en) 1991-10-25 1995-06-13 Cytech Biomedical, Inc. Method of performing assays for biomolecules and solid supports for use in such methods
WO1993015230A1 (en) 1992-01-22 1993-08-05 Abbott Laboratories Calibration reagents for semi-quantitative binding assays and devices
US5137609A (en) 1992-01-31 1992-08-11 Biometric Imaging Inc. Differential separation assay
US5221454A (en) 1992-01-31 1993-06-22 Biometric Imaging Inc. Differential separation assay
EP0631669B1 (en) 1992-03-20 2004-07-14 Abbott Laboratories Magnetically assisted binding assays using magnetically-labeled binding members
US5445971A (en) 1992-03-20 1995-08-29 Abbott Laboratories Magnetically assisted binding assays using magnetically labeled binding members
US5326692B1 (en) 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US6019944A (en) * 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6156270A (en) 1992-05-21 2000-12-05 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
JP3311752B2 (en) * 1992-07-02 2002-08-05 ソイニ,エルッキ Biospecific multivariate assay
DK0653066T3 (en) * 1992-07-31 1998-09-23 Dade Behring Marburg Gmbh Photoactivatable chemiluminescent matrices
US5395754A (en) * 1992-07-31 1995-03-07 Hybritech Incorporated Membrane-based immunoassay method
US5321492A (en) 1992-08-07 1994-06-14 Miles Inc. Dual function readhead for a reflectance instrument
GB9217864D0 (en) 1992-08-21 1992-10-07 Unilever Plc Monitoring method
US5356782A (en) 1992-09-03 1994-10-18 Boehringer Mannheim Corporation Analytical test apparatus with on board negative and positive control
US6399397B1 (en) 1992-09-14 2002-06-04 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
EP0588153B1 (en) 1992-09-14 1996-12-27 Siemens Aktiengesellschaft Gas sensor
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
GB9226229D0 (en) 1992-12-16 1993-02-10 Granta Lab Ltd Detection of macromolecules
US5358852A (en) 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
US6200820B1 (en) * 1992-12-22 2001-03-13 Sienna Biotech, Inc. Light scatter-based immunoassay
CN1061142C (en) 1992-12-22 2001-01-24 西恩纳生物科技有限公司 Light scatter-based immunoassay
US5327225A (en) 1993-01-28 1994-07-05 The Center For Innovative Technology Surface plasmon resonance sensor
US5422726A (en) * 1993-02-16 1995-06-06 Tyler; Jonathan M. Solid state spectrofluorimeter and method of using the same
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
DE4309393A1 (en) 1993-03-23 1994-09-29 Boehringer Mannheim Gmbh Reducing the hook effect in immunoassays with particulate carrier material
DE4310142A1 (en) * 1993-03-29 1994-10-06 Boehringer Mannheim Gmbh Immunologically active conjugates and a method for their preparation
JP3479100B2 (en) * 1993-06-02 2003-12-15 帝国臓器製薬株式会社 Immunochemical simple semi-quantitative method and apparatus
FI932866A0 (en) 1993-06-21 1993-06-21 Labsystems Oy Separeringsfoerfarande
US5658443A (en) 1993-07-23 1997-08-19 Matsushita Electric Industrial Co., Ltd. Biosensor and method for producing the same
US5484867A (en) * 1993-08-12 1996-01-16 The University Of Dayton Process for preparation of polyhedral oligomeric silsesquioxanes and systhesis of polymers containing polyhedral oligomeric silsesqioxane group segments
US5837546A (en) 1993-08-24 1998-11-17 Metrika, Inc. Electronic assay device and method
US5512131A (en) * 1993-10-04 1996-04-30 President And Fellows Of Harvard College Formation of microstamped patterns on surfaces and derivative articles
US5464741A (en) 1993-10-08 1995-11-07 Henwell, Inc. Palladium (II) octaethylporphine alpha-isothiocyanate as a phosphorescent label for immunoassays
JP2614707B2 (en) * 1993-10-20 1997-05-28 株式会社エルジ化学 Method for producing an emulsion polymer having a hollow structure
US5352582A (en) 1993-10-28 1994-10-04 Hewlett-Packard Company Holographic based bio-assay
US5455475A (en) 1993-11-01 1995-10-03 Marquette University Piezoelectric resonant sensor using the acoustoelectric effect
EP0653625B1 (en) * 1993-11-12 2002-09-11 Inverness Medical Switzerland GmbH Reading devices for teststrips
DE69328180D1 (en) * 1993-11-12 2000-04-27 Unilever Plc Analyzer and their application
US5527711A (en) 1993-12-13 1996-06-18 Hewlett Packard Company Method and reagents for binding chemical analytes to a substrate surface, and related analytical devices and diagnostic techniques
EP0744966B1 (en) * 1994-02-17 2002-08-07 THE PROCTER & GAMBLE COMPANY Porous absorbent materials having modified surface characteristics and methods for making the same
US5663213A (en) 1994-02-28 1997-09-02 Rohm And Haas Company Method of improving ultraviolet radiation absorption of a composition
GB9416002D0 (en) * 1994-08-08 1994-09-28 Univ Cranfield Fluid transport device
US6117090A (en) 1994-08-25 2000-09-12 Caillouette; James C. Method and apparatus for detecting amine producing organisms in the vagina
US5599668A (en) * 1994-09-22 1997-02-04 Abbott Laboratories Light scattering optical waveguide method for detecting specific binding events
ES2169107T3 (en) 1994-09-23 2002-07-01 Inverness Medical Switzerland Control method and devices for use therein.
GB9419267D0 (en) 1994-09-23 1994-11-09 Unilever Plc Assay devices
US5620850A (en) * 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US5571684A (en) 1994-11-07 1996-11-05 Litmus Concepts, Inc. Assay for proline iminopeptidase and other hydrolytic activities
US5728352A (en) 1994-11-14 1998-03-17 Advanced Care Products Disposable electronic diagnostic instrument
EP0793806B1 (en) 1994-11-24 2003-04-09 Inverness Medical Switzerland GmbH Recovery of and uses of specific binding agents
US5866434A (en) * 1994-12-08 1999-02-02 Meso Scale Technology Graphitic nanotubes in luminescence assays
KR0151203B1 (en) 1994-12-08 1998-12-01 이헌조 Multi-electrode type biosensor
US5489988A (en) * 1995-01-03 1996-02-06 Motorola Environmental sensor and method therefor
EP0724156A1 (en) 1995-01-26 1996-07-31 Nippon Paint Co., Ltd. Kit for immunologically assaying biological substance and assay process
US5569608A (en) 1995-01-30 1996-10-29 Bayer Corporation Quantitative detection of analytes on immunochromatographic strips
JP3962789B2 (en) * 1995-02-21 2007-08-22 ダブリュー. シディキー,イクバール Mixing / separation apparatus and method using magnetic particles
GB9505425D0 (en) * 1995-03-17 1995-05-03 Unilever Plc Assay devices
US5534132A (en) 1995-05-04 1996-07-09 Vreeke; Mark Electrode and method for the detection of an affinity reaction
KR0156176B1 (en) 1995-06-01 1998-12-01 구자홍 Electrochemical immune biosensor
DE69609967D1 (en) 1995-06-05 2000-09-28 Kimberly Clark Co Dye precursor and containing these compositions
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell
US5518689A (en) 1995-09-05 1996-05-21 Bayer Corporation Diffused light reflectance readhead
EP0864090A4 (en) 1995-09-07 2000-08-30 Agen Biomedical Ltd Method and apparatus for quantitative and semi-quantitative determination of an analyte
US5788863A (en) 1995-12-13 1998-08-04 Becton Dickinson And Company Apparatus and method for conducting an assay using reverse flow through a membrane
US5837547A (en) 1995-12-27 1998-11-17 Caribbean Microparticles Corporation Flow cytometer calibration method
US5945281A (en) 1996-02-02 1999-08-31 Becton, Dickinson And Company Method and apparatus for determining an analyte from a sample fluid
US6287871B1 (en) 1996-03-19 2001-09-11 University Of Utah Research Foundation System for determining analyte concentration
EP0890104B1 (en) * 1996-03-29 2001-08-01 The University Of British Columbia Platelet count assay using platelet granule proteins
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6387707B1 (en) 1996-04-25 2002-05-14 Bioarray Solutions Array Cytometry
US5968839A (en) 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
ES2121565T6 (en) 1996-05-17 1998-11-16 Mercury Diagnostics Inc A disposable device for use in a sampling of body fluids.
US5951492A (en) 1996-05-17 1999-09-14 Mercury Diagnostics, Inc. Methods and apparatus for sampling and analyzing body fluid
DE69724249D1 (en) 1996-05-23 2003-09-25 Inverness Medical Switzerland Improvements in or relating to specific binding assays
DE19622458C2 (en) * 1996-05-24 1998-03-26 Senslab Ges Zur Entwicklung Un Enzymatic-electrochemical single-step affinity sensor for the quantitative determination of analytes in aqueous media and affinity assay
DE19621133A1 (en) * 1996-05-24 1997-11-27 Boehringer Mannheim Gmbh Determination method with oligomerized receptors
EP0901620B1 (en) 1996-05-28 2002-01-09 Zeptosens AG Optical detection apparatus for chemical analyses of small volumes of samples
US5852229A (en) 1996-05-29 1998-12-22 Kimberly-Clark Worldwide, Inc. Piezoelectric resonator chemical sensing device
US6004530A (en) 1996-06-04 1999-12-21 Roche Diagnostics Gmbh Use of metallo-porphyrin conjugates for the detection of biological substances
US6444423B1 (en) 1996-06-07 2002-09-03 Molecular Dynamics, Inc. Nucleosides comprising polydentate ligands
US5876944A (en) * 1996-06-10 1999-03-02 Bayer Corporation Method for amplification of the response signal in a sandwich immunoassay
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
WO1998001744A1 (en) * 1996-07-10 1998-01-15 Cambridge Imaging Limited Improved imaging system for fluorescence assays
US5660790A (en) 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
US6020047A (en) * 1996-09-04 2000-02-01 Kimberly-Clark Worldwide, Inc. Polymer films having a printed self-assembling monolayer
US6001658A (en) * 1996-09-13 1999-12-14 Diagnostic Chemicals Limited Test strip apparatus and method for determining presence of analyte in a fluid sample
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US6194220B1 (en) * 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5798273A (en) 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
DE69617427T2 (en) 1996-09-27 2002-07-11 Unilever Nv Production of test strips
DE69626016D1 (en) 1996-09-27 2003-03-06 Inverness Medical Switzerland Test kit and devices
EP0833157B1 (en) 1996-09-27 2002-11-20 Inverness Medical Switzerland GmbH Assay reagents and devices
US5910940A (en) 1996-10-08 1999-06-08 Polaroid Corporation Storage medium having a layer of micro-optical lenses each lens generating an evanescent field
US6165798A (en) 1996-10-10 2000-12-26 University Of British Columbia Optical quantification of analytes in membranes
US5922537A (en) 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US5922550A (en) 1996-12-18 1999-07-13 Kimberly-Clark Worldwide, Inc. Biosensing devices which produce diffraction images
US6048623A (en) * 1996-12-18 2000-04-11 Kimberly-Clark Worldwide, Inc. Method of contact printing on gold coated films
US5962995A (en) 1997-01-02 1999-10-05 Applied Advanced Technologies, Inc. Electron beam accelerator
US6407492B1 (en) 1997-01-02 2002-06-18 Advanced Electron Beams, Inc. Electron beam accelerator
US5827748A (en) 1997-01-24 1998-10-27 The United States Of America As Represented By The Secretary Of The Navy Chemical sensor using two-dimensional lens array
US6057165A (en) 1997-02-07 2000-05-02 Becton, Dickinson And Company Quality control procedure for membrane flow-through diagnostic assay devices
EP0859230A1 (en) 1997-02-10 1998-08-19 Cranfield University Detection of analytes using electrochemistry
GB2322192B (en) 1997-02-14 2001-01-31 Unilever Plc Assay devices
US6391558B1 (en) 1997-03-18 2002-05-21 Andcare, Inc. Electrochemical detection of nucleic acid sequences
US6180288B1 (en) * 1997-03-21 2001-01-30 Kimberly-Clark Worldwide, Inc. Gel sensors and method of use thereof
US6235471B1 (en) 1997-04-04 2001-05-22 Caliper Technologies Corp. Closed-loop biochemical analyzers
EP0872736A1 (en) 1997-04-18 1998-10-21 Byk Gulden Italia S.p.A. Assay utilizing magnetic particles
US6103536A (en) * 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
US6171780B1 (en) * 1997-06-02 2001-01-09 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US6613583B1 (en) 1997-06-27 2003-09-02 Igen International, Inc. Electrochemiluminescent label based on multimetallic assemblies
US6136611A (en) 1997-07-31 2000-10-24 Research International, Inc. Assay methods and apparatus
EP0898169B1 (en) 1997-08-11 2002-02-06 F. Hoffmann-La Roche Ag Microparticle enhanced light scattering assay and microparticle reagents therefor
US6080391A (en) 1997-08-14 2000-06-27 Novo Nordisk A/S Reduction of malodour
JP2001514388A (en) 1997-08-29 2001-09-11 ファーティリティー・アコースティックス・インコーポレーテッド Method and apparatus for rapidly analyzing an analyte in a biological sample
US5906921A (en) 1997-09-29 1999-05-25 Matsushita Electric Industrial Co., Ltd. Biosensor and method for quantitative measurement of a substrate using the same
US5989924A (en) 1997-09-30 1999-11-23 Becton, Dickinson And Company Device for determining an analyte in a sample
WO1999018438A1 (en) 1997-10-02 1999-04-15 Aclara Biosciences, Inc. Capillary assays involving separation of free and bound species
US6617488B1 (en) 1997-10-14 2003-09-09 Indicator Technologies, Inc. Method and apparatus for indicating the conditions in an absorbent article
US6174646B1 (en) * 1997-10-21 2001-01-16 Konica Corporation Image forming method
US6077669A (en) 1997-11-04 2000-06-20 Becton Dickinson And Company Kit and method for fluorescence based detection assay
US6087184A (en) 1997-11-10 2000-07-11 Beckman Coulter, Inc. Opposable-element chromatographic assay device for detection of analytes
US6030792A (en) * 1997-11-13 2000-02-29 Pfizer Inc Assays for measurement of protein fragments in biological media
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
US6074725A (en) * 1997-12-10 2000-06-13 Caliper Technologies Corp. Fabrication of microfluidic circuits by printing techniques
EP1046027A1 (en) 1997-12-11 2000-10-25 Quidel Corporation One-step fluorescent immunosensor test
US6060256A (en) 1997-12-16 2000-05-09 Kimberly-Clark Worldwide, Inc. Optical diffraction biosensor
DE69818104D1 (en) * 1997-12-30 2003-10-16 Pharmacia Biosystems Ab Using a new calibrator in a method and a device and test kit with this calibrator
KR100593712B1 (en) 1998-01-22 2006-06-30 루미넥스 코포레이션 Microparticles having a plurality of fluorescent signal
DE19811622A1 (en) 1998-03-17 1999-09-23 Lre Technology Partner Gmbh Laboratory instrument incorporating split test card housing
DE69904307D1 (en) 1998-03-19 2003-01-16 Max Planck Gesellschaft Production of coated with more layers of particles and hollow shells by electrostatic self-organization of nanokompositmehrlagen on decomposable template
GB9807134D0 (en) 1998-04-02 1998-06-03 Unilever Plc Test methods devices and test kits
US6368873B1 (en) * 1998-04-09 2002-04-09 Applied Biotech, Inc. Identification of human urine for drug testing
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
US6241863B1 (en) 1998-04-27 2001-06-05 Harold G. Monbouquette Amperometric biosensors based on redox enzymes
US6451607B1 (en) 1998-05-07 2002-09-17 Litmus Concepts, Inc. External dried-reagent control for analytical test devices
US6139961A (en) 1998-05-18 2000-10-31 Rohm And Haas Company Hollow sphere organic pigment for paper or paper coatings
JPH11326603A (en) 1998-05-19 1999-11-26 Seiko Epson Corp Microlens array and its production thereof, and display
WO1999064864A9 (en) 1998-06-12 2000-03-23 New Horizons Diagnostics Inc Optimizing sensitivity in colloidal colorimetric flow through and lateral flow tests
US6030840A (en) * 1998-06-15 2000-02-29 Nen Life Sciences, Inc. Neutral enhancement of lanthanides for time resolved fluorescence
US6183972B1 (en) * 1998-07-27 2001-02-06 Bayer Corporation Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect
US6171870B1 (en) * 1998-08-06 2001-01-09 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
US6281006B1 (en) 1998-08-24 2001-08-28 Therasense, Inc. Electrochemical affinity assay
WO2000019199A1 (en) 1998-09-29 2000-04-06 Fertility Acoustics Inc. A method of and device for determining ovulation in mammals
GB9821526D0 (en) 1998-10-02 1998-11-25 Genosis Inc Capture assay
US6284472B1 (en) 1998-10-05 2001-09-04 Dade Behring Inc. Method for extending the range of an immunoassay
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
BE1012241A3 (en) 1998-10-21 2000-08-01 D Tek Analyte screening method and kit for implementing such a method.
FI982422A0 (en) 1998-11-09 1998-11-09 Arctic Diagnostics Oy Porphyrin compounds, their conjugates, and methods of analysis based on the use of these conjugates
US6261779B1 (en) 1998-11-10 2001-07-17 Bio-Pixels Ltd. Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
WO2000078917A1 (en) 1999-06-18 2000-12-28 Umedik, Inc. Device and method for analyzing a biologic sample
US6455861B1 (en) 1998-11-24 2002-09-24 Cambridge Research & Instrumentation, Inc. Fluorescence polarization assay system and method
US6221579B1 (en) 1998-12-11 2001-04-24 Kimberly-Clark Worldwide, Inc. Patterned binding of functionalized microspheres for optical diffraction-based biosensors
US6579673B2 (en) 1998-12-17 2003-06-17 Kimberly-Clark Worldwide, Inc. Patterned deposition of antibody binding protein for optical diffraction-based biosensors
US6660379B1 (en) 1999-02-05 2003-12-09 University Of Maryland, Baltimore Luminescence spectral properties of CdS nanoparticles
CA2364288A1 (en) 1999-02-11 2000-08-17 Robert D. Macphee Enzyme-linked immuno-magnetic electrochemical biosensor
US6585939B1 (en) 1999-02-26 2003-07-01 Orchid Biosciences, Inc. Microstructures for use in biological assays and reactions
KR20010108273A (en) 1999-02-26 2001-12-07 추후제출 Analyzing strip having a fluid cell and a method of analyzing a sample
US6787368B1 (en) 1999-03-02 2004-09-07 Helix Biopharma Corporation Biosensor method for detecting analytes in a liquid
US6287783B1 (en) 1999-03-18 2001-09-11 Biostar, Inc. Optical assay device and method
US6511814B1 (en) * 1999-03-26 2003-01-28 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6815218B1 (en) 1999-06-09 2004-11-09 Massachusetts Institute Of Technology Methods for manufacturing bioelectronic devices
US6294392B1 (en) 1999-07-21 2001-09-25 The Regents Of The University Of California Spatially-encoded analyte detection
CN1227532C (en) 1999-09-29 2005-11-16 科学技术振兴事业团 High sensitive immunoassay
US6306665B1 (en) 1999-10-13 2001-10-23 A-Fem Medical Corporation Covalent bonding of molecules to an activated solid phase material
US6136549A (en) 1999-10-15 2000-10-24 Feistel; Christopher C. systems and methods for performing magnetic chromatography assays
USD450854S1 (en) 1999-11-04 2001-11-20 Therasense, Inc. Glucose strip
US6331438B1 (en) 1999-11-24 2001-12-18 Iowa State University Research Foundation, Inc. Optical sensors and multisensor arrays containing thin film electroluminescent devices
WO2001038873A3 (en) 1999-11-24 2002-07-11 Biotronic Technologies Inc Devices and methods for detecting analytes using electrosensor having capture reagent
US6171646B1 (en) 1999-12-09 2001-01-09 Engineered Glass Products, Llc Method for making an abrasion and scratch resistant coated glass article
US6399295B1 (en) 1999-12-17 2002-06-04 Kimberly-Clark Worldwide, Inc. Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors
US6509196B1 (en) 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
US20020004246A1 (en) * 2000-02-07 2002-01-10 Daniels Robert H. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
US6255066B1 (en) 2000-02-08 2001-07-03 Allan L. Louderback Bacterial vaginosis screening technique and a diagnostic kit for use therein
US20010055776A1 (en) 2000-02-11 2001-12-27 Dale Greenwalt High throughput cell-based assay kits
EP1281089A1 (en) 2000-02-23 2003-02-05 Besst-Test APS METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE
US6607922B2 (en) 2000-03-17 2003-08-19 Quantum Design, Inc. Immunochromatographic assay method and apparatus
JP2001349891A (en) * 2000-04-03 2001-12-21 Unilever Nv Test method and device
JP2001349892A (en) * 2000-04-03 2001-12-21 Unilever Nv Test method and device
US6436722B1 (en) 2000-04-18 2002-08-20 Idexx Laboratories, Inc. Device and method for integrated diagnostics with multiple independent flow paths
US6627459B1 (en) 2000-04-19 2003-09-30 Applied Biotech, Inc. Immunoassay controls
WO2001098785B1 (en) 2000-06-19 2002-11-14 Univ Arizona Rapid flow-based immunoassay microchip
US7892854B2 (en) 2000-06-21 2011-02-22 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US6372895B1 (en) * 2000-07-07 2002-04-16 3M Innovative Properties Company Fluorogenic compounds
JP2004504931A (en) * 2000-08-02 2004-02-19 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ Production of the polymer electrolyte capsules by surface precipitation
DE10042023C2 (en) 2000-08-08 2003-04-10 Biognostic Ag Capsules encapsulating solid particles of signal-generating organic substances, and their use in bioassays for detection of target molecules in a sample
US6420128B1 (en) * 2000-09-12 2002-07-16 Lifescan, Inc. Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same
US7052831B2 (en) 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
US6653149B1 (en) 2000-10-16 2003-11-25 Applied Biotech Inc. Specimen collection device and method
US6720007B2 (en) * 2000-10-25 2004-04-13 Tufts University Polymeric microspheres
US20020164659A1 (en) 2000-11-30 2002-11-07 Rao Galla Chandra Analytical methods and compositions
DE10062062C1 (en) 2000-12-13 2002-02-28 Draegerwerk Ag Electrochemical sensor used e.g. in control technology has a microprocessor integrated on chip of an electronic device for receiving and further processing signals from the device
US6524864B2 (en) * 2000-12-28 2003-02-25 Aurora L. Fernandez Decastro Test strip for simultaneous detection of a plurality of analytes
US20030162236A1 (en) 2001-03-26 2003-08-28 Response Biomedical Corporation Compensation for variability in specific binding in quantitative assays
JP2002303629A (en) 2001-04-06 2002-10-18 Matsushita Electric Ind Co Ltd Immune chromatography device and method for determining substance to be tested using the same
JP4152193B2 (en) * 2001-04-27 2008-09-17 アイセンス・アクチエンゲゼルシャフトEyeSense AG Blood glucose concentration measuring apparatus
CN100386627C (en) 2001-07-03 2008-05-07 包 刚;许扬清 Filtration-based microarray chip
US6818456B2 (en) 2001-07-20 2004-11-16 Varian, Inc. Color contrast system for lateral flow immunoassay tests
US6669908B2 (en) 2001-07-25 2003-12-30 Applied Biotech, Inc. Urine test device
WO2003058246A1 (en) 2001-12-24 2003-07-17 Kimberly-Clark Worldwide, Inc. Flow-through assay with an internal calibration system using polyelectrolyte
US7214427B2 (en) 2002-03-21 2007-05-08 Aviva Biosciences Corporation Composite beads comprising magnetizable substance and electro-conductive substance
GB2409720B (en) 2002-10-08 2007-05-09 Tara Nylese Portable diagnostic device and method for determining temporal variations in concentrations
US20040121334A1 (en) * 2002-12-19 2004-06-24 Kimberly-Clark Worldwide, Inc. Self-calibrated flow-through assay devices

Cited By (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092036A1 (en) * 2002-09-11 2004-05-13 Lattec I/S Device for analysing analyte compounds and use hereof
WO2005057216A1 (en) * 2003-11-21 2005-06-23 Kimberly-Clark Worldwide, Inc. Method of reducing the sensitivity of assay devices
US7863057B2 (en) 2003-12-08 2011-01-04 Charm Sciences, Inc. Method and assay for detection of residues
US20080274566A1 (en) * 2003-12-08 2008-11-06 Charm Sciences, Inc. Method and assay for detection of residues
US7410808B1 (en) 2003-12-08 2008-08-12 Charm Sciences, Inc. Method and assay for detection of residues
US20110070127A1 (en) * 2003-12-08 2011-03-24 Saul Steven J Method and Assay for Detection of Residues
US9063137B2 (en) 2003-12-08 2015-06-23 Charm Sciences, Inc. Method and assay for detection of residues
US20110097820A1 (en) * 2003-12-23 2011-04-28 Kimberly-Clark Worldwide, Inc. Swab-Based Diagnostic Systems
US20050221504A1 (en) * 2004-04-01 2005-10-06 Petruno Patrick T Optoelectronic rapid diagnostic test system
US9243997B2 (en) 2004-04-01 2016-01-26 Alverix, Inc. Lateral flow assay systems and methods
US7521259B2 (en) 2004-04-01 2009-04-21 Alverix, Inc. Assay test strips with multiple labels and reading same
US20070185679A1 (en) * 2004-04-01 2007-08-09 Petruno Patrick T Indicating status of a diagnostic test system
US20050221505A1 (en) * 2004-04-01 2005-10-06 Petruno Patrick T Optoelectronic rapid diagnostic test system
US9091631B2 (en) 2004-04-01 2015-07-28 Alverix, Inc. Lateral flow assay systems and methods
US20070231922A1 (en) * 2004-04-01 2007-10-04 Petruno Patrick T Assay test strips with multiple labels and reading same
GB2433989B (en) * 2004-07-01 2009-04-08 Central Science Lab Analyte detection system
US20080289068A1 (en) * 2004-07-01 2008-11-20 Forsite Diagnostics Limited Analyte Detection System
WO2006003394A1 (en) * 2004-07-01 2006-01-12 Central Science Laboratory (Csl) Representing The Secretary Of State For Environment, Food And Rural Affairs Analyte detection system
GB2433989A (en) * 2004-07-01 2007-07-11 Central Science Lab Analyte delection system
US7763433B2 (en) 2004-07-01 2010-07-27 Forsite Diagnostics Limited Analyte detection system
JP4988546B2 (en) * 2005-01-28 2012-08-01 持田製薬株式会社 Immunochromatographic test device and a semi-quantitative method using the same
US20060286616A1 (en) * 2005-03-22 2006-12-21 Miki Furukawa Menopause stage monitor
US20090180928A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips with multiple labels and reading same
US8128871B2 (en) 2005-04-22 2012-03-06 Alverix, Inc. Lateral flow assay systems and methods
US7521260B2 (en) 2005-04-22 2009-04-21 Alverix, Inc. Assay test strips and reading same
US8043867B2 (en) 2005-04-22 2011-10-25 Petruno Patrick T Assay test strips and reading same
US20090180929A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips with multiple labels and reading same
US20090180926A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips and reading same
US20090180927A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips and reading same
US20090180925A1 (en) * 2005-04-22 2009-07-16 Alverix, Inc. Assay test strips and reading same
US20090214383A1 (en) * 2005-04-22 2009-08-27 Alverix, Inc. Assay test strips with multiple labels and reading same
US20060240541A1 (en) * 2005-04-22 2006-10-26 Petruno Patrick T Lateral flow assay systems and methods
US9891217B2 (en) 2005-04-22 2018-02-13 Alverix, Inc. Assay test strips with multiple labels and reading same
US7595152B2 (en) 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
US20100112547A1 (en) * 2005-07-01 2010-05-06 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
US20100092944A1 (en) * 2005-07-01 2010-04-15 Arbor Vita Corporation Detection of influenza virus
US20070224594A1 (en) * 2005-07-01 2007-09-27 Arbor Vita Corporation Detection of influenza virus
US20070161078A1 (en) * 2005-07-01 2007-07-12 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
WO2007053487A3 (en) * 2005-10-28 2009-01-15 Binax Inc Methods and devices for detection of the strain of a pathogen
WO2007053487A2 (en) * 2005-10-28 2007-05-10 Binax, Inc. Methods and devices for detection of the strain of a pathogen
US20080293041A1 (en) * 2005-10-28 2008-11-27 Binax, Inc. Methods and Devices for Detection of the Strain of a Pathogen
US8153381B2 (en) 2005-10-28 2012-04-10 Alere Scarborough, Inc. Methods for detection of the strain of a pathogen
US20070116595A1 (en) * 2005-11-22 2007-05-24 Petrilla John F Assaying test strips having different capture reagents
US8632730B2 (en) 2005-11-22 2014-01-21 Alverix, Inc. Assaying test strips having different capture reagents
US20070122914A1 (en) * 2005-11-30 2007-05-31 Curry Bo U Obtaining measurements of light transmitted through an assay test strip
US8024148B2 (en) 2005-12-19 2011-09-20 Alverix, Inc. End-of-life disabling of a diagnostic test system
US20080028261A1 (en) * 2005-12-19 2008-01-31 Petruno Patrick T End-of-life disabling of a diagnostic test system
US20070188736A1 (en) * 2006-02-16 2007-08-16 Fouquet Julie E Obtaining measurement and baseline signals for evaluating assay test strips
US20100143884A1 (en) * 2007-01-26 2010-06-10 Arbor Vita Corporations Detection of influenza virus
US8835184B2 (en) 2007-09-14 2014-09-16 Biosensia Patents Limited Analysis system
US20110171754A1 (en) * 2007-09-14 2011-07-14 Gareth Redmond Analysis system
JP5487104B2 (en) * 2008-08-22 2014-05-07 デンカ生研株式会社 Test device according to membrane assay having a control display unit
EP2325640A1 (en) * 2008-08-22 2011-05-25 DENKA SEIKEN Co., Ltd. Test apparatus for membrane assay equipped with reference display section
EP2325640A4 (en) * 2008-08-22 2011-11-02 Denka Seiken Kk Test apparatus for membrane assay equipped with reference display section
US20110143458A1 (en) * 2008-08-22 2011-06-16 Denka Seiken Co., Ltd. Test device for membrane assay comprising reference display section
EP2180319A1 (en) * 2008-10-21 2010-04-28 Kaiwood Technology Co., Ltd. Biological test strip
JP2010101886A (en) * 2008-10-21 2010-05-06 Kaiwood Technology Co Ltd Bioassay strip
US20110244598A1 (en) * 2008-12-03 2011-10-06 Roche Diagnostics Operations, Inc. Test Element Having Combined Control and Calibration Zone
US8569073B2 (en) * 2008-12-03 2013-10-29 Roche Diagnostics Operations Inc. Test element having combined control and calibration zone
US8455263B2 (en) 2008-12-30 2013-06-04 Jin Po Lee Quantitative analyte assay device and method
EP2384428A1 (en) * 2008-12-30 2011-11-09 Jin Po Lee Quantitative analyte assay device and method
US9557329B2 (en) 2008-12-30 2017-01-31 Assurance Llc Quantitative analyte assay device and method
US20100167264A1 (en) * 2008-12-30 2010-07-01 Jin Po Lee Quantitative analyte assay device and method
US8900881B2 (en) 2008-12-30 2014-12-02 Jin Po Lee Quantitative analyte assay device and method
EP3244189A1 (en) * 2008-12-30 2017-11-15 Jin Po Lee Quantitative analyte assay device and method
EP2384428A4 (en) * 2008-12-30 2013-03-06 Jin Po Lee Quantitative analyte assay device and method
US20100175455A1 (en) * 2009-01-14 2010-07-15 Alverix, Inc. Methods and materials for calibration of a reader
US8643837B2 (en) * 2009-01-14 2014-02-04 Alverix, Inc. Methods and materials for calibration of a reader
US20120171702A1 (en) * 2009-06-30 2012-07-05 Monash University Quantitative and self-calibrating chemical analysis using paper-based microfluidic systems
US9116146B2 (en) * 2009-06-30 2015-08-25 Monash University Quantitative and self-calibrating chemical analysis using paper-based microfluidic systems
WO2011020724A1 (en) * 2009-08-17 2011-02-24 Dst Diagnostische Systeme & Technologien Gmbh Test system for visual analysis
US9261502B2 (en) * 2009-08-17 2016-02-16 Dst Diagnostische Systeme & Technologien Gmbh Test system for visual analysis
US20130022965A1 (en) * 2009-08-17 2013-01-24 Dst Diagnostische Systeme & Technologien Gmbh Test system for visual analysis
USD667228S1 (en) 2009-09-24 2012-09-18 Yuyama Manufacturing Co., Ltd. Sheet for a drug bag
US8313956B2 (en) 2010-03-09 2012-11-20 Nokia Corporation Apparatus and associated methods
WO2011110734A1 (en) * 2010-03-09 2011-09-15 Nokia Corporation Apparatus for analyte sensing and associated methods
US20110223689A1 (en) * 2010-03-09 2011-09-15 Nokia Croporation Apparatus and associated methods
US9199232B2 (en) 2010-04-07 2015-12-01 Biosensia Patents Limited Flow control device for assays
WO2011124991A3 (en) * 2010-04-07 2011-12-29 Biosensia Patents Limited Flow control device for assays
US20120225422A1 (en) * 2011-03-03 2012-09-06 RoMonics, LLC Method and device employing a non-receptor ligand interaction with nanoparticles or other solid phase followed by specific detection
CN102539769A (en) * 2011-12-22 2012-07-04 正元盛邦(天津)生物科技有限公司 Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography
US9885712B2 (en) 2012-11-15 2018-02-06 Ortho-Clinical Diagnostics, Inc. Calibrating assays using reaction time
CN104937418A (en) * 2012-11-15 2015-09-23 奥索临床诊断有限公司 Calibrating assays using reaction time
WO2017112780A1 (en) * 2015-12-22 2017-06-29 Polymer Technology Systems, Inc. Systems and methods for quantification of creatinine using a creatinine-protein conjugate

Also Published As

Publication number Publication date Type
US20030124739A1 (en) 2003-07-03 application
US7651841B2 (en) 2010-01-26 grant
DE60237395D1 (en) 2010-09-30 grant
US20030119204A1 (en) 2003-06-26 application
KR20040068976A (en) 2004-08-02 application
KR101043888B1 (en) 2011-06-22 grant

Similar Documents

Publication Publication Date Title
US4366241A (en) Concentrating zone method in heterogeneous immunoassays
US6136549A (en) systems and methods for performing magnetic chromatography assays
US5858648A (en) Assays using reference microparticles
US4959307A (en) Immunoseparating strip
US4604365A (en) Immunoprecipitation assay
US5171695A (en) Determination of analyte concentration using two labelling markers
US5039607A (en) Method for immunochromatographic analysis
US5202268A (en) Multi-layered test card for the determination of substances in liquids
US5939272A (en) Non-competitive threshold ligand-receptor assays
US5521102A (en) Controlled sensitivity immunochromatographic assay
US4786594A (en) Enzyme immunoassay
US5807755A (en) Determination of ambient concentrations of several analytes
US7186566B2 (en) Combining transmittance detection and chromatographic strip techniques for quantification of analyte in biological fluids
US5089391A (en) Threshold ligand-receptor assay
US20040161859A1 (en) Lateral flow immunoassay controls
US6924153B1 (en) Quantitative lateral flow assays and devices
EP0200381A1 (en) A solid phase system for use in ligand-receptor assays
US4594327A (en) Assay method for whole blood samples
US20040043511A1 (en) Membrane-based assay devices
US5389523A (en) Liposome immunoanalysis by flow injection assay
US6737278B1 (en) Ligand binding assay and kit with a separation zone for disturbing analytes
US5780308A (en) Calibration reagents for semiquanitative binding assays and devices
US5716778A (en) Concentrating immunochemical test device and method
US4250394A (en) Apparatus for determining immunochemical substances
US4434236A (en) Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue

Legal Events

Date Code Title Description
AS Assignment

Owner name: KIMBERLY-CLARK WORLDWIDE, INC., WISCONSIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEI, NING;SONG, XUEDONG;REEL/FRAME:012861/0257

Effective date: 20020311